MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

Search

Envista Holdings Corp

Gesloten

SectorGezondheidszorg

19.67 -0.61

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

19.34

Max

19.82

Belangrijke statistieken

By Trading Economics

Inkomsten

17M

18M

Verkoop

-36M

617M

EPS

0.24

Winstmarge

2.918

Werknemers

12,300

EBITDA

-7.1M

39M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

-3.59% downside

Dividenden

By Dow Jones

Volgende Winsten

31 jul 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

640M

3.4B

Vorige openingsprijs

20.28

Vorige sluitingsprijs

19.67

Nieuwssentiment

By Acuity

20%

80%

31 / 376 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

Envista Holdings Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

16 jul 2025, 23:56 UTC

Acquisities, Fusies, Overnames

Alimentation Couche-Tard Ends Bid to Buy Seven & I Holdings -- 2nd Update

16 jul 2025, 23:43 UTC

Acquisities, Fusies, Overnames

Santos 2Q Output Rises 1% as Takeover Campaign Continues

16 jul 2025, 23:00 UTC

Acquisities, Fusies, Overnames

Alimentation Couche-Tard Ends Bid to Buy Seven & I Holdings -- Update

16 jul 2025, 22:38 UTC

Acquisities, Fusies, Overnames

Alimentation Couche-Tard Withdraws Seven & i Acquisition Proposal

16 jul 2025, 23:44 UTC

Marktinformatie

Gold Steady; Geopolitical Tensions in Middle East Support -- Market Talk

16 jul 2025, 23:42 UTC

Marktinformatie

Nikkei May Fall as Yen Strengthens -- Market Talk

16 jul 2025, 23:24 UTC

Marktinformatie

Australian Job Market Data to Shape RBA Calls -- Market Talk

16 jul 2025, 23:18 UTC

Acquisities, Fusies, Overnames

Santos Now Expects 2025 Production of 90 Million-95 Million BOE

16 jul 2025, 23:18 UTC

Acquisities, Fusies, Overnames

Santos Cuts Top End of 2025 Production Guidance

16 jul 2025, 23:17 UTC

Acquisities, Fusies, Overnames

Santos: Production Recovery Underway in Cooper Basin

16 jul 2025, 23:17 UTC

Acquisities, Fusies, Overnames

Santos: Over 200 Wells, Several Upstream Compressors in Cooper Basin Shut In

16 jul 2025, 23:17 UTC

Acquisities, Fusies, Overnames

Santos: Cooper Basin Production Impacted by Floods in 2Q

16 jul 2025, 23:16 UTC

Acquisities, Fusies, Overnames

Santos: Pikka Phase 1 Project in Alasia 89% Complete

16 jul 2025, 23:16 UTC

Acquisities, Fusies, Overnames

Santos Keeps 2025 Major Development Project Capex Guidance Unchanged

16 jul 2025, 23:13 UTC

Acquisities, Fusies, Overnames

Santos Had Gearing of 20.5% at End-June, Excluding Operating Leases

16 jul 2025, 23:13 UTC

Acquisities, Fusies, Overnames

Santos Says Moomba CCS Phase 1 Project Performing to Expectations

16 jul 2025, 23:12 UTC

Acquisities, Fusies, Overnames

Santos Narrows 2025 Unit Production Cost Guidance to US$7.00-US$7.40/BOE

16 jul 2025, 23:12 UTC

Acquisities, Fusies, Overnames

Santos 1H Free Cash Flow From Operations US$1.1 Billion

16 jul 2025, 23:11 UTC

Acquisities, Fusies, Overnames

Santos 2Q Free Cash Flow From Operations US$620 Million

16 jul 2025, 23:11 UTC

Acquisities, Fusies, Overnames

Santos 2Q Oil, Natural Gas Output 22.2 Million BOE

16 jul 2025, 23:11 UTC

Acquisities, Fusies, Overnames

Santos 2Q Oil, Natural Gas Sales Volumes 23.9 Million BOE

16 jul 2025, 23:11 UTC

Acquisities, Fusies, Overnames

Santos 2Q Oil, Natural Gas Sales Volumes Up 3% on 1Q

16 jul 2025, 23:11 UTC

Acquisities, Fusies, Overnames

Santos 2Q Oil, Natural Gas Output Up 1% on 1Q

16 jul 2025, 22:43 UTC

Marktinformatie

Alcoa Using High Costs of More Production to Battle Tariff -- Market Talk

16 jul 2025, 22:35 UTC

Marktinformatie
Winsten

Global Equities Roundup: Market Talk

16 jul 2025, 22:35 UTC

Marktinformatie
Winsten

Replacing Aluminum Imports With U.S. Production Not Seen Feasible -- Market Talk

16 jul 2025, 22:33 UTC

Marktinformatie
Winsten

Alcoa Will Continue to Ship Aluminum Outside of the U.S. -- Market Talk

16 jul 2025, 22:28 UTC

Marktinformatie
Winsten

Aluminum Price in U.S. Doesn't Offset Tariff Costs, Alcoa says -- Market Talk

16 jul 2025, 22:22 UTC

Marktinformatie
Winsten

Market Talk Roundup: Latest on U.S. Politics

16 jul 2025, 22:22 UTC

Marktinformatie
Winsten

Alcoa Considers Restart of Idle Capacity at Indiana Smelter -- Market Talk

Peer Vergelijking

Prijswijziging

Envista Holdings Corp Prognose

Koersdoel

By TipRanks

-3.59% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 19.31 USD  -3.59%

Hoogste 24 USD

Laagste 15 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Envista Holdings Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

11 ratings

4

Buy

6

Hold

1

Sell

Technische score

By Trading Central

15.98 / N/ASteun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

31 / 376 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Envista Holdings Corp

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.